The biomedical lab after COVID-19: cascading effects of the lockdown on lab-based research programs and graduate students in Canada

by Vincent Maranda, Edward Yakubovich
Published 2020-10-01

Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success

by Galaxia M. Rodriguez, Edward Yakubovich, Barbara C. Vanderhyden
Published 2023-12-01

Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis

by Edward Yakubovich, David P. Cook, Galaxia M. Rodriguez, Barbara C. Vanderhyden
Published 2023-12-01

Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses

by John Abou-Hamad, Jonathan J. Hodgins, Edward Yakubovich, Barbara C. Vanderhyden, Michele Ardolino, Luc A. Sabourin
Published 2023-12-01

BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy

by Salar Farokhi Boroujeni, Galaxia Rodriguez, Kristianne Galpin, Edward Yakubovich, Humaira Murshed, Dalia Ibrahim, Sara Asif, Barbara C. Vanderhyden
Published 2023-11-01

NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens

by Galaxia M. Rodriguez, Galaxia M. Rodriguez, Edward Yakubovich, Edward Yakubovich, Humaira Murshed, Vincent Maranda, Kristianne J.C. Galpin, Kristianne J.C. Galpin, Alison Cudmore, Alison Cudmore, Andrew M. R. Hanna, Elizabeth Macdonald, Elizabeth Macdonald, Shashankan Ramesh, Shashankan Ramesh, Kenneth Garson, Kenneth Garson, Barbara C. Vanderhyden, Barbara C. Vanderhyden
Published 2024-01-01